Preparation and Immunological Properties of a Nanovaccine Against Based on Gold Nanoparticles and Detoxified Lipopolysaccharide

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2021 May 6

PMID 33953860

Citations 1

Authors

Faezeh Najafzadeh

Asghar Tanomand

Azam Haddadi

Jafar Majidi

Affiliations

Soon will be listed here.

Citing Articles

Preparation and evaluation of the exotoxin A nano-gold conjugate as a vaccine candidate for infections.

Abbasi M, Tanomand A, Kafilzadeh F, Zolghadri S, Hosainzadegan H Iran J Basic Med Sci. 2022; 24(10):1366-1372.

PMID: 35096294 PMC: 8769522. DOI: 10.22038/IJBMS.2021.58367.12960.

References

Patri A, Umbreit T, Zheng J, Nagashima K, Goering P, Francke-Carroll S . Energy dispersive X-ray analysis of titanium dioxide nanoparticle distribution after intravenous and subcutaneous injection in mice. J Appl Toxicol. 2009; 29(8):662-72. DOI: 10.1002/jat.1454. View

Rokhsartalab-Azar S, Shapouri R, Rahnema M, Najafzadeh F, Kianmehr A . Synthesis, characterization and immunological properties of Escherichia coli 0157:H7 lipopolysaccharide- diphtheria toxoid conjugate vaccine. Iran J Microbiol. 2015; 7(3):150-5. PMC: 4676984. View

Farajnia S, Najar Peerayeh S, Tanomand A, Majidi J, Goudarzi G, Naghili B . Protective efficacy of recombinant exotoxin A--flagellin fusion protein against Pseudomonas aeruginosa infection. Can J Microbiol. 2014; 61(1):60-4. DOI: 10.1139/cjm-2014-0501. View

Dykman L, Khlebtsov N . Immunological properties of gold nanoparticles. Chem Sci. 2017; 8(3):1719-1735. PMC: 5396510. DOI: 10.1039/c6sc03631g. View

Dykman L . Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases. Expert Rev Vaccines. 2020; 19(5):465-477. PMC: 7196924. DOI: 10.1080/14760584.2020.1758070. View

Safari D, Marradi M, Chiodo F, Th Dekker H, Shan Y, Adamo R . Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine. Nanomedicine (Lond). 2012; 7(5):651-62. DOI: 10.2217/nnm.11.151. View

Li Y, Shi Z, Radauer-Preiml I, Andosch A, Casals E, Luetz-Meindl U . Bacterial endotoxin (lipopolysaccharide) binds to the surface of gold nanoparticles, interferes with biocorona formation and induces human monocyte inflammatory activation. Nanotoxicology. 2017; 11(9-10):1157-1175. DOI: 10.1080/17435390.2017.1401142. View

Pier G . Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol. 2007; 297(5):277-95. PMC: 1994162. DOI: 10.1016/j.ijmm.2007.03.012. View

Muruato L, Tapia D, Hatcher C, Kalita M, Brett P, Gregory A . Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei. Clin Vaccine Immunol. 2017; 24(11). PMC: 5674190. DOI: 10.1128/CVI.00206-17. View

10.

Sanchez-Villamil J, Tapia D, Torres A . Development of a Gold Nanoparticle Vaccine against Enterohemorrhagic Escherichia coli O157:H7. mBio. 2019; 10(4). PMC: 6692519. DOI: 10.1128/mBio.01869-19. View

11.

Gupta S, Masinick S, Garrett M, Hazlett L . Pseudomonas aeruginosa lipopolysaccharide binds galectin-3 and other human corneal epithelial proteins. Infect Immun. 1997; 65(7):2747-53. PMC: 175387. DOI: 10.1128/iai.65.7.2747-2753.1997. View

12.

Sekimukai H, Iwata-Yoshikawa N, Fukushi S, Tani H, Kataoka M, Suzuki T . Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs. Microbiol Immunol. 2019; 64(1):33-51. PMC: 7168429. DOI: 10.1111/1348-0421.12754. View

13.

Ryu J, Wui S, Ko A, Lee Y, Do H, Kim H . Increased Immunogenicity and Protective Efficacy of a Vaccine in Mice Using an Alum and De--Acylated Lipooligosaccharide Adjuvant System. J Microbiol Biotechnol. 2017; 27(8):1539-1548. DOI: 10.4014/jmb.1706.06009. View

14.

Ayazian Mavi S, Modarressi M, Mohebali M, Shojaee S, Zeraati H, Teimouri A . Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of in BALB/c mice. Infect Drug Resist. 2019; 12:2519-2530. PMC: 6699518. DOI: 10.2147/IDR.S209270. View

15.

Torres A, Gregory A, Hatcher C, Vinet-Oliphant H, Morici L, Titball R . Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine. Vaccine. 2014; 33(5):686-92. PMC: 4304905. DOI: 10.1016/j.vaccine.2014.11.057. View

16.

Dos Santos Haupenthal D, Mendes C, Silveira G, Zaccaron R, Correa M, Nesi R . Effects of treatment with gold nanoparticles in a model of acute pulmonary inflammation induced by lipopolysaccharide. J Biomed Mater Res A. 2019; 108(1):103-115. DOI: 10.1002/jbm.a.36796. View

17.

Keene A, Allaway R, Sadrieh N, Tyner K . Gold nanoparticle trafficking of typically excluded compounds across the cell membrane in JB6 Cl 41-5a cells causes assay interference. Nanotoxicology. 2010; 5(4):469-78. DOI: 10.3109/17435390.2010.533792. View

18.

Najafzadeh F, Shapouri R, Rahnema M, Rokhsartalab Azar S, Kianmehr A . Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity. Jundishapur J Microbiol. 2015; 8(6):e17712. PMC: 4541022. DOI: 10.5812/jjm.8(5)2015.17712. View

19.

Thomas L, Cripps A, Kyd J . Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection. Vaccine. 2009; 27(25-26):3324-30. DOI: 10.1016/j.vaccine.2009.01.085. View

20.

Gregory A, Williamson E, Prior J, Butcher W, Thompson I, Shaw A . Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity. Vaccine. 2012; 30(48):6777-82. PMC: 3488157. DOI: 10.1016/j.vaccine.2012.09.021. View